CABP2 Patient Registry and Natural History Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Medical Center Goettingen
About this trial
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Eligibility criteria
Qualifiers
A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry
Disqualifiers
Patients with evidence of non-CABP2 molecular genetic diagnoses
Trial design
Treatments tested in this trial
- Molecular genetic testing and audiometry
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
1University Medical Center Goettingen37075, Göttingen Germany
Sponsors and collaborators
University Medical Center Goettingen
Lead sponsor
Source ClinicalTrials.gov